bioAffinity launches federal CyPath Lung distribution partnership with AvMEDICAL
The company debuted its noninvasive lung cancer test at NAVREF 2026. This partnership expands federal access to the test and addresses a significant health burden within the veteran community.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed